PAC0018PR: Pancreatic Poorly Differentiated Ductal Adenocarcinoma

TRACE-PDTX platform


Patient
Sex Male
Age at Time of Collection 78
Race / Ethnicity / Not Specified
Patient Tumor
Histology Pancreatic Poorly Differentiated Ductal Adenocarcinoma
Primary Tissue pancreas
Collection Site pancreas
Tumor Type Primary
Grade Grade 3
Stage pT3N1M0R0 ( Classification: TNM staging system)
PDX model Engraftment
Host Strain Name Site Type Material Material Status Passage
NMRI nude interscapular fat pad heterotopic tissue fragment fresh 0, 1, 2, 3
Model Quality Control
Technique Description Passage
Histology high concordance between xenograft and patient tumour 0,1,2,3
Fingerprinting high concordance between xenograft and patient tumour 0,1,2,3
Collection (Current Model)
Age 78
Diagnosis Pancreatic Poorly Differentiated Ductal Adenocarcinoma
Type Primary
PDX Mouse PAC0018PR
Collection Site pancreas
Sex Male
Race / Ethnicity Not specified / Not Specified
Date Regimen Started Regimen Dose Best Response Duration (Months)
Not specified Gemcitabine 1000 mg/m2 weekly for 3 wk; every 4 wk for six cycles Progressive Disease Not specified
Not specified Cisplatin and Gemcitabine every 28 d / Gemcitabine 1000 mg/m2 on days 1 and 15 plus cisplatin 50 mg/m2 on days 1 and 15 Progressive Disease Not specified / Not specified

Sample ID:     Histology:     Tumor Type: Engrafted Tumor     Passage:     Platform: